,
Blocking information on COVID-19 can fuel the spread of misinformation, Nature, vol.580, p.306, 2020. ,
The online competition between pro-and anti-vaccination views ,
, Nature, 2020.
Scientists are drowning in COVID-19 papers. Can new tools keep them afloat? Science, 2020. ,
,
Strengthening the Reporting of Observational Studies in Epidemiology for respondent-driven sampling studies, J Clin Epidemiol, 2015. ,
Speed Science: The risks of swiftly spreading coronavirus research. Reuters, 2020. ,
Adverse Consequences of Rushing a SARS ,
, Vaccine: Implications for Public Trust, 2020.
Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials, Lancet, vol.357, issue.9253, pp.373-80, 2001. ,
Association is not causation: treatment effects cannot be estimated from observational data in heart failure, Eur Heart J, vol.321, issue.7256, pp.3417-3438, 2000. ,
Small studies: strengths and limitations, Eur Respir J, England, 2008. ,
Journal Press Releases and Editorials Associated with Randomized and Observational Studies in High-Impact Medical Journals: A Cohort Study, PLoS One, vol.10, issue.12, p.145294, 2015. ,
Head to head comparison of the propensity score and the high-dimensional propensity score matching methods, BMC Med Res Methodol, vol.16, p.22, 2016. ,
The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials, Stat Med, vol.26, issue.1, pp.20-36, 2007. ,
Big data and large sample size: a cautionary note on the potential for bias, Clin Transl Sci, vol.7, issue.4, pp.342-348, 2014. ,
Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research, Bmj, p.6409, 2013. ,
Bias and causal associations in observational research, Lancet, vol.359, issue.9302, pp.248-52, 2002. ,
Discussing hidden bias in observational studies, Ann Intern Med, vol.115, issue.11, pp.901-906, 1991. ,
Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis, Lancet, 2020. ,
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-inhuman trial, Lancet, 2020. ,
Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19), JAMA Cardiol, 2020. ,
Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality, Jama, vol.2020, issue.2, pp.168-77 ,
A Trial of Lopinavir, N Engl J Med, vol.2020, issue.19, pp.1787-1799 ,
,
, , p.19
Triple combination of interferon beta-1b, lopinavirritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, Lancet, 2020. ,
Remdesivir in adults with severe COVID-19: a randomised, doubleblind, placebo-controlled, multicentre trial, Lancet, vol.395, pp.1569-1578, 2020. ,
Remdesivir for the Treatment of Covid-19 -Preliminary Report, 2020. ,
,
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19, N Engl J Med, 2020. ,
,
,
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19, N Engl J Med, 2020. ,
,
, Effect of Convalescent Plasma Therapy on Time to Clinical, p.20
, Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial, Jama, 2020.
Dexamethasone in Hospitalized Patients with Covid-19 -Preliminary Report, N Engl J Med, 2020. ,
Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review, Ann Intern Med, 2020. ,
,
COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine, J Clin Epidemiol, 2020. ,
, Covid-19 Era and Beyond, N Engl J Med, 2020.
Research in the Context of a Pandemic, N Engl J Med, 2020. ,
An organizational analysis of the World Health Organization: narrowing the gap between promise and performance, N Engl J Med, vol.40, issue.6, 1995. ,
Global regulators work towards alignment on policy approaches and regulatory flexibility during COVID-19 -update #3, Int J Antimicrob Agents, 2020. ,
Counteracting Health Misinformation: A Role for Medical Journals?, Jama, vol.2019, issue.19, pp.1863-1864 ,
Addressing Health-Related Misinformation on Social Media, Jama, vol.320, issue.23, pp.2417-2418, 2018. ,
Protecting the Value of Medical Science in the Age of Social Media and "Fake News, Jama, vol.320, issue.23, pp.2415-2416, 2018. ,
The spread of true and false news online, Science, vol.359, issue.6380, pp.1146-1151, 2018. ,
Hindu pride boosts pseudoscience, Science, vol.363, pp.679-680, 2019. ,
,
Weaponized Health Communication: Twitter Bots and Russian Trolls Amplify the Vaccine Debate, Am J Public Health, vol.108, issue.10, pp.1378-1384, 2018. ,
Medical Education in the Era of Alternative Facts, N Engl J Med, vol.2017, issue.7, pp.607-609 ,
Infographic: The Best And Worst Science News Sites, 2017. ,
Building rules in public: Our approach to synthetic & manipulated media, p.22 ,
Predicting social response to infectious disease outbreaks from internet-based news streams, United States, vol.263, issue.c, pp.551-564, 2017. ,
,
Medical Misinformation: Vet the Message!, Eur Heart J, vol.40, issue.5, pp.404-405, 2019. ,
,
Grading quality of evidence and strength of recommendations, Bmj, vol.328, issue.7454, 2004. ,
Twitter-based learning for continuing medical education?, Eur Heart J, 2020. ,
Citation analysis may severely underestimate the impact of clinical research as compared to basic research, PLoS One, vol.23, issue.4, p.62395, 2008. ,
, Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA
, Against Novel Coronavirus
, In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead
Rush to share good news on COVID-19 drugs is undermining science ,